XBiotech has successfully completed a European Phase III study of Xilonix™ for the treatment of advanced colorectal cancer. Learn More

Xilonix™

Lead antibody candidate has shown breakthrough potential for treating advanced cancer. Completing two pivotal Phase 3 clinical studies for treating patients with advanced colorectal cancer.

Learn More

Infectious Diseases

Broad pipeline of naturally-derived True Human™ therapeutic antibodies may offer unmatched safety and efficacy across a range of serious diseases.

Learn More